Tango Therapeutics, Inc. (TNGX) stock analysis

TNGX · Tango Therapeutics, Inc.

Latest recorded price: USD 24.17

Sector and industry: Healthcare · Biotechnology

Fiscal 2025 figures: revenue growth 35.9%, free cash flow margin -224.3%. The model flags 1 risk signal for this company (1 high severity).

Similar companies in Healthcare